CN114939144A - 一种治疗筋脉失养型跟痛症的中药组合物 - Google Patents
一种治疗筋脉失养型跟痛症的中药组合物 Download PDFInfo
- Publication number
- CN114939144A CN114939144A CN202210604467.1A CN202210604467A CN114939144A CN 114939144 A CN114939144 A CN 114939144A CN 202210604467 A CN202210604467 A CN 202210604467A CN 114939144 A CN114939144 A CN 114939144A
- Authority
- CN
- China
- Prior art keywords
- parts
- calcaneodynia
- treating
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 210000002435 tendon Anatomy 0.000 title claims abstract description 35
- 208000002720 Malnutrition Diseases 0.000 title claims abstract description 27
- 230000001071 malnutrition Effects 0.000 title claims abstract description 27
- 235000000824 malnutrition Nutrition 0.000 title claims abstract description 27
- 208000015380 nutritional deficiency disease Diseases 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 13
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 13
- 241000725145 Homalomena Species 0.000 claims abstract description 13
- 244000018716 Impatiens biflora Species 0.000 claims abstract description 13
- 235000015912 Impatiens biflora Nutrition 0.000 claims abstract description 13
- 240000000249 Morus alba Species 0.000 claims abstract description 13
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 13
- 235000005155 Tanacetum balsamita Nutrition 0.000 claims abstract description 13
- 241000427159 Achyranthes Species 0.000 claims abstract description 12
- 241000195954 Lycopodium clavatum Species 0.000 claims abstract description 12
- 241000758794 Asarum Species 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 9
- 244000236658 Paeonia lactiflora Species 0.000 claims abstract description 6
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims abstract description 6
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 5
- 229940079593 drug Drugs 0.000 claims description 11
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims 2
- 240000000031 Achyranthes bidentata Species 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 20
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 15
- 210000003205 muscle Anatomy 0.000 abstract description 10
- 230000008961 swelling Effects 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 206010061363 Skeletal injury Diseases 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 238000011282 treatment Methods 0.000 description 35
- 208000024891 symptom Diseases 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 9
- 210000000988 bone and bone Anatomy 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 210000000474 heel Anatomy 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 241000212322 Levisticum officinale Species 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 239000001645 levisticum officinale Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 208000034783 hypoesthesia Diseases 0.000 description 5
- 241000125175 Angelica Species 0.000 description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 description 4
- 235000006484 Paeonia officinalis Nutrition 0.000 description 4
- 241001106477 Paeoniaceae Species 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010016228 Fasciitis Diseases 0.000 description 3
- 241000931143 Gleditsia sinensis Species 0.000 description 3
- 241000913745 Spatholobus Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000000459 calcaneus Anatomy 0.000 description 3
- 210000003195 fascia Anatomy 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000001872 metatarsal bone Anatomy 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 235000017965 Asarum canadense Nutrition 0.000 description 2
- 206010005963 Bone formation increased Diseases 0.000 description 2
- 235000000385 Costus speciosus Nutrition 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000606265 Valeriana jatamansi Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 235000014687 Zingiber zerumbet Nutrition 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 210000003423 ankle Anatomy 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001260012 Bursa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000014770 Foot disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000006578 abscission Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000008321 arterial blood flow Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 201000010934 exostosis Diseases 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000000281 joint capsule Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- VTRAEEWXHOVJFV-UHFFFAOYSA-N olmesartan Chemical compound CCCC1=NC(C(C)(C)O)=C(C(O)=O)N1CC1=CC=C(C=2C(=CC=CC=2)C=2NN=NN=2)C=C1 VTRAEEWXHOVJFV-UHFFFAOYSA-N 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗筋脉失养型跟痛症的中药组合物,其特征在于,所述中药组合物由如下质量份数的原料要制成:当归20~30份、白芍20~30份、川芎10~20份、生地黄10~20份、鸡血藤15~25份、千年健10~20份、淮牛膝10~20份、伸筋草10~15份、透骨草10~15份、皂角刺20~30份、桂枝15~30份、桑枝15~30份、细辛5~10份、白鲜皮10~15份;本发明提供的治疗失养型跟痛症的中药组合物有养筋通络、活血化瘀、消肿止痛的效果,全方药物功效均围绕治疗骨伤疼痛之疾,对治疗筋脉失养型跟痛症有良好的效果。
Description
技术领域
本发明属于医疗领域,具体涉及一种治疗筋脉失养型跟痛症的中 药组合物。
背景技术
足跟痛是足跟一侧或两侧疼痛,不红不肿,行走不便,又称脚跟 痛。是由于足跟的骨质、关节、滑囊、筋膜等处病变引起的疾病。常 见的为跖筋膜炎,往往发生在久立或行走工作者,长期、慢性轻伤引 起,表现为跖筋膜纤维断裂及修复过程,在跟骨下方偏内侧的筋膜近 处骨质增生及压痛,侧位X射线片显示跟骨骨刺。
中医学认为,足跟痛多属肝肾阴虚、痰湿、血热等因所致。肝主 筋、肾主骨,肝肾亏虚,筋骨失养,复感风寒湿邪或慢性劳损便导致 经络瘀滞,气血运行受阻,使筋骨肌肉失养而发病。
现目前,需要一种筋通络、活血化瘀、消肿止痛的失养型跟痛症 治疗药物。
发明内容
为了解决以上技术问题,本发明提供了一种治疗筋脉失养型跟痛 症的中药组合物,全方药物功效均围绕治疗骨伤疼痛之疾,有养筋、 活血、止痛、强筋、抗炎、消肿的作用。
为了达到解决上述技术问题的技术效果,本发明是通过以下技术 方案实现的:一种治疗筋脉失养型跟痛症的中药组合物,其特征在于, 所述中药组合物由如下质量份数的原料要制成:当归20份~30份、 白芍20份~30份、川芎10份~20份、生地黄10份~20份、鸡血 藤15份~25份、千年健10份~20份、淮牛膝10份~20份、伸筋 草10份~15份、透骨草10份~15份、皂角刺20份~30份、桂枝 15份~30份、桑枝15份~30份、细辛5份~10份、白鲜皮10份~ 15份;
进一步的,所述中药组合物由如下质量份数的原料药制成:当归 15份~25份、白芍23份~27份、川芎12份~18份、生地黄12份~ 18份、鸡血藤17份~23份、千年健12份~18份、淮牛膝12份~ 18份、伸筋草11份~14份、透骨草11份~14份、皂角刺22份~ 28份、桂枝15份~28份、桑枝15份~28份、细辛6份~9份、白 鲜皮12份~15份;
进一步的,所述中药组合物由如下质量份数的原料药制成:当归 20份~25份、白芍25份~27份、川芎14份~18份、生地黄14份~ 18份、鸡血藤19份~23份、千年健14份~18份、淮牛膝14份~ 18份、伸筋草12份~14份、透骨草12份~14份、皂角刺24份~ 28份、桂枝18份~28份、桑枝18份~28份、细辛7份~9份、白 鲜皮12份~14份;
方解
君药:当归、白药。当归始载于《神农本草经》:“主咳逆上气,…… 诸恶疮疡,金创”。味甘、辛,性温,入肝、心、脾经,能补血活血、 化瘀生新,充补有形之血,治疗风湿痹痛,跌扑损伤,有抑制炎症, 抗血栓的作用。白芍始载于《神农本草经》:“主邪气腹痛,除血痹,破坚积,寒热疝瘕,止痛,利小便,益气”,味苦、酸、甘,性微寒, 入肝脾经,能养血、柔肝、止痛,治疗四肢挛急疼痛,合当归补血养 筋,充盈经脉,并有除血痹,破坚积寒热疝瘕,止痛之功;有明显镇 痛,解痉作用,对急性炎症水肿有明显抑制作用。
臣药:川芎、生地黄、鸡血藤、千年健、淮牛膝。川芎始载于《神 农本草经》:“主中风入脑,头痛,寒痹,筋挛缓急,金创,妇人血 闭无子”,辛温能散,入肝、胆、心胞经,能行气调血,活血祛瘀, 治疗跌扑肿痛,风湿痹痛,有镇痛效应,增加肢体血流量,降低血管 阻力,预防血栓形成的作用。生地黄始载于《神农本草经》:“主折 跌,绝筋,伤中,逐血痹,填骨髓,长肌肉,作汤除寒热积聚,除痹”。 味甘,性寒,入心、肝、肾经,能清热凉血,治疗血热出血,有止血, 抗溃疡作用。鸡血藤载于《本草纲目拾遗》:“壮筋骨……,治老人 气血虚弱,手足麻木,瘫痪等证”。味苦、甘,性温,入肝、肾经, 能活血补血,舒筋活络,治疗风湿痹痛,肢体麻木,有抗炎,降低血 管阻力的作用。千年健性苦、辛,味温,入肝、肾经,能祛风湿,壮 筋骨,治疗风寒湿痹,拘挛麻木,筋骨痿软,有明显的抗炎、镇痛作 用。淮牛膝味苦甘酸,性平,入肝、肾经,能逐瘀,强筋骨,治疗跌 扑伤痛,筋骨无力,有降低全血粘度,抗凝作用。
佐药:伸筋草、透骨草、皂角刺、桂枝、桑枝、细辛、白鲜皮。 伸筋草味苦、辛,性温,入肝、脾、肾经,能祛风除湿,舒筋活络, 治疗风寒湿痹,关节痠痛,屈伸不利,跌打损伤,有明显镇痛作用。 透骨草味甘、辛,性温,入肺、肝经,能祛风除湿,舒筋活络,活血 止痛,治疗风湿疼痛,筋骨拘挛,肢体麻木,有镇痛,抗风湿,抗炎, 杀菌,收敛创面的作用。皂角刺始载于《本草图经》:“消肿托毒, 排脓通络”,辛温通散,入肝、肺经,能消肿排脓、搜风通络、托毒透里,治疗肢体肿痛,痈疽、疥鲜,有增加动脉血流量,抑制多种细 菌、真菌的作用。桂枝味辛、甘,性温,入心、肺、膀胱经,能温通 经脉,发汗解肌,助阳化气,治疗关节痹痛,血寒经闭,水肿,有扩 张血管,改善血液循环,镇痛,抗炎,抗过敏的作用。桑枝味微苦, 性平,入肝经,能祛风湿,利关节,治疗风湿痹症,关节痠痛麻木, 有较强的抗炎作用。细辛味辛,性温,入、肺、肾经,能祛风止痛, 治疗风湿痹痛,有镇痛,抗炎,扩张血管的作用。白鲜皮味苦,性寒, 入脾、胃、膀胱经,能清热燥湿,祛风解毒,治疗风湿热痹,湿热疮 毒,有抗炎,抑制多种致病性真菌的作用。
本发明的有益效果是;
本发明提供的治疗失养型跟痛症的中药组合物有养筋通络、活血 化瘀、消肿止痛的效果,全方药物功效均围绕治疗骨伤疼痛之疾,对 治疗筋脉失养型跟痛症有良好的效果。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述,显 然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施 例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性 劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。
实施例1
一种治疗筋脉失养型跟痛症的中药组合物由如下原料药制成:当 归20g~30g、白芍20g~30g、川芎10g~20g、生地黄10g~20g、鸡 血藤15g~25g、千年健10g~20g、淮牛膝10g~20g、伸筋草10g~ 15g、透骨草10g~15g、皂角刺20g~30g、桂枝15g~30g、桑枝15g~30g、细辛5g~10g、白鲜皮10g~15g。
实施例2
一种治疗筋脉失养型跟痛症的中药组合物由如下原料药制成:当 归15g~25g、白芍23g~27g、川芎12g~18g、生地黄12g~18g、鸡 血藤17g~23g、千年健12g~18g、淮牛膝12g~18g、伸筋草11g~ 14g、透骨草11g~14g、皂角刺22g~28g、桂枝15g~28g、桑枝15g~28g、细辛6g~9g、白鲜皮12g~15g。
实施例3
一种治疗筋脉失养型跟痛症的中药组合物由如下原料药制成:当 归20g~25g、白芍25g~27g、川芎14g~18g、生地黄14g~18g、鸡 血藤19g~23g、千年健14g~18g、淮牛膝14g~18g、伸筋草12g~ 14g、透骨草12g~14g、皂角刺24g~28g、桂枝18g~28g、桑枝18g~28g、细辛7g~9g、白鲜皮12g~14g。
实施例4
本实施例为运用一种治疗筋脉失养型跟痛症的中药组合物治疗 治疗筋脉失养型跟痛症的典型病例;
患者:张某,性别:女,年龄:48岁,销售人员。2021年6月 23日初诊;
主诉右足跟部疼痛6月年,近10日症状明显加重,休息后症状 缓解不明显;
初诊:检查见右足跟无红肿,足底跟骨跖筋膜起点处压痛明显, 跟骨侧面亦有轻压痛;舌淡红,苔稍腻,脉沉细弱;
右足侧位X线片示:左跟骨骨质增生;
证属筋脉失养,治宜养血活血,疏筋通络止痛;
方用当归30g、白芍30g、川芎15g、生地黄15g、鸡血藤15g、 千年健15g、淮牛膝15g、伸筋草15g、透骨草15g、皂角刺30g、桂 枝15g、桑枝15g、细辛10g、白鲜皮10g;
打粉后用高度白酒和温水调匀外敷,每日1次,每次6小时,连 续治疗10日;
筋脉失养,气血运行不畅,瘀阻经脉,不通则痛。本法养血活血, 疏筋通络,解除骨刺对跟部脂肪垫和滑囊的刺激,使无菌性炎症更易 吸收,从而达到治疗跟痛症的目的;
2021年7月3日复诊,患者述疼痛较前减轻,守上方治疗1月, 疼痛基本消失。
实施例5
本实施例为运用一种治疗筋脉失养型跟痛症的中药组合物治疗 治疗筋脉失养型跟痛症的普通病例;
1、临床资料
1.1、一般资料
选取2019年1月至2021年12月在我院就诊的跟痛症患者257 例,采用抽签法随机分为治疗组130例和对照组127例。治疗组男 69例,女61例;年龄35~65岁,平均(46.00±10.11)岁;病程2~ 4个月,平均(2.94±0.25)个月;病变数165个。对照组男67例, 女60例;年龄35~65岁,平均(45.38±9.27)岁;病程2~4个月, 平均(3.00±0.38)个月;病变数161个。2组患者在性别、年龄、 病程、病变数等方面比较,差异无统计学意义(P>0.05),具有可比 性。
1.2、诊断标准
依据《中医骨伤科学》、《实用骨科学》及《坎贝尔骨科手术学》 中关于跟痛症的诊断标准进行拟定:(1)主诉为跟下疼痛,晨起或 稍坐加重,稍走疼痛减轻。白天加重,傍晚加重。减轻负重后减轻; (2)足跟负重区内下侧局限性压痛阳性。患侧与健侧相比可见轻度肿胀和发红;(3)X线片可有跟骨骨刺。MRI可示跖筋膜撕裂、跟骨 水肿等;(4)缓慢发病,病程较长,无明显外伤史;(5)中医辨证 符合筋脉失养证。
1.3、纳入标准
(1)符合上述诊断标准;(2)自愿加入本研究;(3)年龄35~ 65岁;(4)2周内无其他相关治疗。
1.4、排除标准
(1)患有足部其他疾病者,如痛风、肿瘤、跟骨骨髓炎、结核 等;(2)妊娠或哺乳期妇女;(3)合并心脑血管、肝肾、造血或内 分泌系统等严重原发性疾病者;(4)对本研究使用中药过敏者;(5) 足踝部皮肤有破损溃疡、感染者。
1.5、脱落标准
①治疗期间症状加重,终止治疗者;②依从性差,未完成所规定 的全部治疗方案者;③治疗期间失访者。
2、方法
2.1、治疗方法
对照组:双氯芬酸二乙胺乳胶剂(扶他林;厂商:北京诺华制药有 限公司;国药准字:H19990291;规格:20g/支)。用法用量:将扶他 林药膏涂抹至患处,用手指将药膏反复涂抹至完全吸收。每次用量约 为0.5g,每日3次,10日为1个疗程。治疗时间为2个疗程。
治疗组:在对照组的基础上加用养筋通脉散外敷患处治疗,药物 组成:当归30g、白芍30g、川芎15g、生地黄15g、鸡血藤15g、千 年健15g、淮牛膝15g、伸筋草15g、透骨草15g、皂角刺30g、桂枝 15g、桑枝15g、细辛10g、白鲜皮10g。上述中药打粉后用高度白酒 和温水调匀外敷,每日1次,每次6小时,10日为一个疗程,治疗时 间为2个疗程。
2.2、疗效评定标准
按照《中医病证诊断疗效评价》标准。治愈:症状完全消失, 行走自如,参加体力劳动时无症状。显效:症状明显改善,能正常行 走,但劳累后症状会有所加重。有效:症状减轻,但在行走时会加重。 无效:症状未改善,行走困难。
2.3、观察指标
治疗前及治疗后2、4、6周,2组分别按照视觉模拟评分法(VAS) 评估疼痛情况;采用美国足踝外科协会踝-后足评分量表(AOFAS)评 价患足功能。
2.4、统计学方法
采用SPSS25.0软件进行统计分析。组内比较采用配对t检验, 组间比较采用单因素方差分析;计数资料采用卡方检验。以P<0.05 为差异有统计学意义。
3、结果
3.1、脱落情况
治疗后2,4,6周,治疗组随访分别为126例、124例、124例, 对照组随访分别为125例、125例、121例。具体脱落病例数为:治 疗组2周4例、4周2例,对照组2周2例、6周4例。两组脱落例 数比较,差异无统计学意义(P>0.05)。
3.2、两组患者临床疗效比较
治疗后4周,治疗组治愈率、总有效率均显著高于对照组,差异 有统计学意义(P<0.05),见表1。
表1两组跟痛症患者治疗后4周临床疗效比较
注与对照组比较,*P<0.05。
3.3、两组患者治疗前后VAS评分比较
治疗后2,4,6周,两组VAS评分较治疗前均下降(P<0.05); 且治疗组明显低于对照组(P<0.05),见表2。
表2两组跟痛症患者治疗前后VAS评分比较
注与本组治疗前比较,*P<0.05;与对照组同期比较,2)P<0.05。
3.4、两组患者治疗前后AOFAS评分比较
治疗后2,4,6周,两组AOFAS评分较治疗前均升高(P<0.05); 且治疗组明显高于对照组(P<0.05),见表3。
表3两组跟痛症患者治疗前后AOFAS评分比较
注与本组治疗前比较,*P<0.05;与对照组同期比较,#P<0.05。
3.5、不良反应
治疗期间,两照组患者均未出现明显不良反应。
4、结论
养筋通脉散外敷治疗跟痛症,总有效率高,操作简单、有效、方 便,且复发率低,患者接受度及依从性较高,值得临床推广。
综上所述,本发明提供的治疗失养型跟痛症的中药组合物有养筋 通络、活血化瘀、消肿止痛的效果,全方药物功效均围绕治疗骨伤疼 痛之疾,对治疗筋脉失养型跟痛症有良好的效果。
在本说明书的描述中,参考术语“一个实施例”、“示例”、“具 体示例”等的描述意指结合该实施例或示例描述的具体特征、结构、 材料或者特点包含于本发明的至少一个实施例或示例中。在本说明书 中,对上述术语的示意性表述不一定指的是相同的实施例或示例。而 且,描述的具体特征、结构、材料或者特点可以在任何的一个或多个 实施例或示例中以合适的方式结合。
以上公开的本发明优选实施例只是用于帮助阐述本发明。优选实 施例并没有详尽叙述所有的细节,也不限制该发明仅为所述的具体实 施方式。显然,根据本说明书的内容,可作很多的修改和变化。本说 明书选取并具体描述这些实施例,是为了更好地解释本发明的原理和 实际应用,从而使所属技术领域技术人员能很好地理解和利用本发明。 本发明仅受权利要求书及其全部范围和等效物的限制。
Claims (4)
1.一种治疗筋脉失养型跟痛症的中药组合物,其特征在于,所述中药组合物由如下质量份数的原料要制成:当归20~30份、白芍20~30份、川芎10~20份、生地黄10~20份、鸡血藤15~25份、千年健10~20份、淮牛膝10~20份、伸筋草10~15份、透骨草10~15份、皂角刺20~30份、桂枝15~30份、桑枝15~30份、细辛5~10份、白鲜皮10~15份。
2.根据权利要求1所述一种治疗筋脉失养型跟痛症的中药组合物,其特征在于,所述中药组合物由如下质量份数的原料药制成:当归15~25份、白芍23~27份、川芎12~18份、生地黄12~18份、鸡血藤17~23份、千年健12~18份、淮牛膝12~18份、伸筋草11~14份、透骨草11~14份、皂角刺22~28份、桂枝15~28份、桑枝15~28份、细辛6~9份、白鲜皮12~15份。
3.根据权利要求1所述一种治疗筋脉失养型跟痛症的中药组合物,其特征在于,所述中药组合物由如下质量份数的原料药制成:当归20~25份、白芍25~27份、川芎14~18份、生地黄14~18份、鸡血藤19~23份、千年健14~18份、淮牛膝14~18份、伸筋草12~14份、透骨草12~14份、皂角刺24~28份、桂枝18~28份、桑枝18~28份、细辛7~9份、白鲜皮12~14份。
4.根据权利要求1-3任意一项所述一种治疗筋脉失养型跟痛症的中药组合物,其公开了一种治疗筋脉失养型跟痛症的中药组合物在治疗筋脉失养型跟痛症中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210604467.1A CN114939144A (zh) | 2022-05-30 | 2022-05-30 | 一种治疗筋脉失养型跟痛症的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210604467.1A CN114939144A (zh) | 2022-05-30 | 2022-05-30 | 一种治疗筋脉失养型跟痛症的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114939144A true CN114939144A (zh) | 2022-08-26 |
Family
ID=82909943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210604467.1A Pending CN114939144A (zh) | 2022-05-30 | 2022-05-30 | 一种治疗筋脉失养型跟痛症的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114939144A (zh) |
-
2022
- 2022-05-30 CN CN202210604467.1A patent/CN114939144A/zh active Pending
Non-Patent Citations (1)
Title |
---|
董方升等: "六味地黄丸配合中药熏洗治疗跟痛症53例" * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102861196B (zh) | 一种接骨中药 | |
CN104383445A (zh) | 一种跌打损伤止痛剂 | |
CN102406870B (zh) | 一种治疗风湿痹痛的药物 | |
CN107823280A (zh) | 一种治疗疼痛的中药组合物及其制备方法 | |
CN114939144A (zh) | 一种治疗筋脉失养型跟痛症的中药组合物 | |
CN102078432A (zh) | 一种治疗皮肤瘙痒的药剂 | |
CN102370836B (zh) | 一种治疗创伤性滑膜炎的外敷中药 | |
CN111450182A (zh) | 治疗风湿骨病的组合物及其制备方法 | |
CN104524471A (zh) | 一种消肿止痛膏 | |
CN101391053B (zh) | 治疗痔疮的中药组合物 | |
CN104706749A (zh) | 一种治疗腰椎肩盘突出症的中药组合物 | |
CN109172693A (zh) | 用于调理宫寒和改善子宫虚寒的妇科凝胶 | |
CN104173765B (zh) | 温热渗透治疗修复运动损伤的中药制剂和药包 | |
CN102764336A (zh) | 一种治疗骨外伤的中药 | |
CN115054640A (zh) | 一种治疗筋脉瘀阻型跟痛症的中药组合物 | |
CN101559185A (zh) | 一种治疗下肢静脉曲张的外用药物 | |
CN101953908A (zh) | 一种治疗腰腿痛的中药组合物及其制备方法 | |
CN105617214A (zh) | 一种治疗疥疮的中药组合物 | |
CN115089653A (zh) | 一种治疗风湿病和颈、腰椎病的中药组合物及其应用 | |
CN105327290A (zh) | 一种治疗糖尿病坏疽的外用中药及其制备方法 | |
CN116077573A (zh) | 一种经络疏通中药药物及其制备方法 | |
CN104524472A (zh) | 一种跌打止痛膏 | |
CN111759882A (zh) | 一种治疗椎间盘突出的纯中药透皮擦剂及其制备方法 | |
CN113144064A (zh) | 一种治疗风寒侵筋骨的酒剂及其制备方法 | |
CN117860838A (zh) | 一种伤科膏及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220826 |
|
RJ01 | Rejection of invention patent application after publication |